Your browser doesn't support javascript.
loading
Synthetic Glyconanoparticles Modulate Innate Immunity but Not the Complement System.
Ghosh, Chandradhish; Priegue, Patricia; Leelayuwapan, Harin; Fuchsberger, Felix F; Rademacher, Christoph; Seeberger, Peter H.
Afiliação
  • Ghosh C; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476 Potsdam, Germany.
  • Priegue P; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476 Potsdam, Germany.
  • Leelayuwapan H; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Arnimallee 22, 14195 Berlin, Germany.
  • Fuchsberger FF; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476 Potsdam, Germany.
  • Rademacher C; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476 Potsdam, Germany.
  • Seeberger PH; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476 Potsdam, Germany.
ACS Appl Bio Mater ; 5(5): 2185-2192, 2022 05 16.
Article em En | MEDLINE | ID: mdl-35435657
ABSTRACT
Nanoparticles that modulate innate immunity can act as vaccine adjuvants and antigen carriers and are promising alternatives to conventional anticancer therapy. Nanoparticles might, upon contact with serum, activate the complement system that might in turn result in clearance and allergic reactions. Herein, we report that ultrasmall glyconanoparticles decorated with nonimmunogenic α-(1-6)-oligomannans trigger an innate immune response without drastically affecting the complement system. These negatively charged glyconanoparticles (10-15 nm) are stable in water and secrete proinflammatory cytokines from macrophages via the NF-κB signaling pathway. The glyconanoparticles can be used as immunomodulators for monotherapy or in combination with drugs and vaccines.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Imunidade Inata Idioma: En Revista: ACS Appl Bio Mater Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Imunidade Inata Idioma: En Revista: ACS Appl Bio Mater Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha